Impact of coronavirus disease 2019 on diabetic patients: An endocrinological perspective for better management
1Department of Biotechnology, Indian Institute of Technology, Roorkee, Uttrakhand, India
*Corresponding author: Himanshu Agrawal, Department of Biotechnology, Indian Institute of Technology, Roorkee, Uttrakhand, India. firstname.lastname@example.org
© 2020 Published by Scientific Scholar on behalf of Journal of Reproductive Healthcare and Medicine
How to cite this article: Agrawal H, Das N, Nathani S, Roy P. Impact of Coronavirus disease 2019 on diabetic patients: An endocrinological perspective for better management. J Reprod Healthc Med 2021;2(Suppl_1):S85-S91.
The current pandemic of coronavirus disease 2019 (COVID-19) has led to severe health-related distress globally. Worldwide, different vaccines have been proven safe and effective against COVID-19. However, at present, immunization is permitted for the individuals involved in health sector in India and therefore still requires special care. Elderly people especially with other chronic ailments are the most vulnerable population for this infection. Diabetes is one such ailment which makes an individual more vulnerable toward this viral infection and if infected, the chances of survival of such individuals are very low. In the current review, we have discussed the endocrine aspects which might be responsible for the high mortality rate due to COVID-19 in diabetic patients.
Severe acute respiratory syndrome coronavirus 2
Coronavirus disease 2019
Angiotensin-converting enzyme 2